ESG
Sanofi announces $150,000 flood relief package for affected communities
Sanofi has pledged to deliver a support package worth $150,000AUD to help address immediate and longer term needs of people impacted by flood in Australia.
The package includes contributions to the Australian Red Cross and BizRebuild. BizRebuild is a business-led initiative developed by the Business Council of Australia to provide practical and on the ground assistance to small and local businesses left devastated by bushfires and floods.
Karen Hood, Country Lead, Australia & New Zealand, said “Our thoughts are with everyone impacted by flood in Queensland and New South Wales, and we’re grateful our people are safe.
“We’ve been working closely with customers and supply chain partners in an effort to ensure our medicines and vaccines are arriving as needed to people in the affected areas, and providing support in the clean-up. This work will continue.
“As a healthcare leader and member of Australia’s business community it is our responsibility to provide needed support to help our communities find solid ground. Our relief package is designed to help address immediate and longer-term needs.”
Sanofi’s support package totals $150,000 and includes:
- $100,000 donation to the Australian Red Cross’ Qld and NSW Floods Appeal to provide urgent relief and ongoing outreach for impacted communities.
- $50,000 donation to BizRebuild. A business-led initiative developed by the Business Council of Australia which will provide grants to local businesses to help them get back on their feet, quickly.
- Sanofi Australia’s five-day volunteering program for employee’s supporting clean up efforts.
Medical
NSW Health to settle ‘largest’ class action
A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]
MoreNews & Trends - Pharmaceuticals
Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap
Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]
MoreNews & Trends - Pharmaceuticals
AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases
Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]
MoreNews & Trends - Pharmaceuticals
PBAC recommendation to reshape prescribing in heart failure
Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]
More